TY - JOUR
T1 - Diagnosis, treatment, and new developments in preeclampsia
AU - Arendt, Katherine W.
AU - Hartman, William
AU - Garovic, Vesna D.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/11
Y1 - 2010/11
N2 - Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.
AB - Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality in the United States and worldwide. Despite its significant prevalence (5% of all otherwise normal pregnancies may be affected), there is no early pregnancy screening test to recognize those at risk. Further, once diagnosed, there is no effective treatment beyond delivery. Emerging data are beginning to uncover the pathogenesis of this complex disease. In this review, the clinical presentation, current management, new evidence regarding pathogenesis, and future possibilities for screening and therapy will be discussed.
KW - Eclampsia
KW - Preeclampsia
KW - Pregnancy induced hypertension
UR - http://www.scopus.com/inward/record.url?scp=79959358220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959358220&partnerID=8YFLogxK
U2 - 10.2174/157340410793362195
DO - 10.2174/157340410793362195
M3 - Review article
AN - SCOPUS:79959358220
SN - 1573-4048
VL - 6
SP - 297
EP - 302
JO - Current Women's Health Reviews
JF - Current Women's Health Reviews
IS - 4
ER -